- Home
- INDV vs EXLS Comparison
INDV vs EXLS Comparison
Compare INDV & EXLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | INDV | EXLS |
|---|---|---|
| Founded | N/A | 1999 |
| Country | United States | United States |
| Employees | 838 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 4.8B |
| IPO Year | 2014 | 2004 |
Fundamental Metrics
Financial Performance| Metric | INDV | EXLS |
|---|---|---|
| Price | $37.58 | $29.40 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $46.80 |
| AVG Volume (30 Days) | 2.0M | ★ 2.5M |
| Earning Date | 06-08-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 8100.00 | 27.27 |
| EPS | ★ 0.69 | 0.43 |
| Revenue | ★ $1,239,000,000.00 | N/A |
| Revenue This Year | N/A | $12.61 |
| Revenue Next Year | N/A | $10.55 |
| P/E Ratio | ★ $54.72 | $67.88 |
| Revenue Growth | ★ 4.29 | N/A |
| 52 Week Low | $11.49 | $26.82 |
| 52 Week High | $41.00 | $48.54 |
Technical Indicators
Market Signals| Indicator | INDV | EXLS |
|---|---|---|
| Relative Strength Index (RSI) | 58.25 | 45.34 |
| Support Level | $29.71 | $29.11 |
| Resistance Level | $37.83 | $32.49 |
| Average True Range (ATR) | 1.15 | 1.12 |
| MACD | -0.32 | -0.04 |
| Stochastic Oscillator | 35.77 | 49.50 |
Price Performance
Historical ComparisonAbout INDV Indivior PLC
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).
About EXLS ExlService Holdings Inc.
ExlService Holdings Inc. is a data analytics and digital operations company that provides data and AI-led solutions and technology-enabled services to clients across industries. The company has four reportable segments. The Insurance segment provides services such as claims management, underwriting support, and analytics solutions. The Healthcare and Life Sciences segment offers data-driven solutions and services to healthcare payers, providers, and life sciences organizations. The Banking, Capital Markets and Diversified Industries segment delivers solutions across financial services and other industries. The International Growth Markets segment focuses on providing data, AI, and digital operations services to clients outside North America.